Related Experiment Video
Updated: Jan 6, 2026

Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System
Published on: October 20, 2023
Anticholinergic and sedative medications use among community dwelling older adults: risk for polypharmacy and poor
Aysu Selcuk1, Volkan Atmis2, Seher Sen2
1Department of Clinical Pharmacy, Faculty of Pharmacy, Ankara University, Ankara, Türkiye. aysuselcuk@ankara.edu.tr.
Background:
Anticholinergic and/or sedative mediations are one of the most commonly prescribed medication groups in older adults. This study aimed to assess the prevalence of anticholinergic and/or sedative mediations use in community dwelling older adults as well as potentially associated factors with their use.
Methods:
A cross sectional study was conducted among community dwelling older adults who accepted invitation for geriatric screening in the Public Education Centres (PEC) in Türkiye. The subgroup study population was selected among those who used at least one medication. The prevalence of anticholinergic and/or sedative mediations use, comprehensive geriatric tests, drug-drug interactions and polypharmacy were assessed. Statistical analysis was performed to identify associated factors with anticholinergic and/or sedative mediations use.
Results:
A total of 608 older adults voluntarily participated in the study from the 16 PEC. Among these 372 were eligible (61%). The prevalence of anticholinergic and/or sedative medications use was 36% among the community dwelling older adults. Polypharmacy was present in 32% of the them. Drug-drug interactions involved anticholinergic and/or sedative medications was common (42%). Polypharmacy (p < 0.001) and poor physical function (frailty, p = 0.026; sarcopenia, p = 0.003; instrumental activities of daily living, p = 0.001; and activities of daily living, p = 0.045) were found to be associated with the use of anticholinergic and/or sedative medications in this study.
Conclusions:
With common anticholinergic and/or sedative mediations use and its associated risk for polypharmacy, poor physical function and drug-drug interactions, their use must be balanced with their potential risks and benefits.
More Related Videos
04:13Using a Real-Time Locating System to Measure Walking Activity Associated with Wandering Behaviors Among Institutionalized Older Adults
Published on: February 8, 2019
06:52Assessment of Dependence in Activities of Daily Living Among Older Patients in an Acute Care Unit
Published on: September 30, 2020
Related Concept Videos
Drug Dosing: Geriatric Patients
Pharmacodynamics in Geriatric Patients: Effects of Age
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption